TACTIC would like to make available technologies in the consortium as accessible as possible to the cancer research community. We are therefore available to answer any questions you may have in this regard. We cover all areas of preclinical research from screening and hit identification, hit validation, protein biochemistry, medicinal chemistry and toxicity studies to clinically relevant cancer models.  Please contact us if you have any questions: Contact